Enveda Biosciences Inc., a biotechnology company that leverages artificial intelligence to develop new medicines, announced today that it has raised $130 million in new funding to deliver clinical ...
USC has embarked on a collaboration with Autobahn Labs, an accelerator for early-stage drug discovery, to identify and advance cutting-edge scientific findings into new therapies - with a special ...
Enveda Therapeutics Inc., a startup that uses artificial intelligence to find promising drug candidates, has raised $130 million just a few months after its last financing. The new funding round was ...